Neoadjuvant chemoradiotherapy for pancreatic cancer is beneficial, but schedules should be improved

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Article number	33
Number of pages	3
Journal	Digestive Medicine Research
Volume	3
Issue number	0
DOIs	https://doi.org/10.21037/dmr-20-99
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{8050a9b7c22a403393a2c2f59116c722,

title = "Neoadjuvant chemoradiotherapy for pancreatic cancer is beneficial, but schedules should be improved",

author = "Tienhoven, \{Geertjan van\} and Eva Versteijne and Besselink, \{Marc G.\} and Wilmink, \{Johanna W.\} and Bruynzeel, \{Anna M.\}",

year = "2020",

doi = "10.21037/dmr-20-99",

language = "English",

volume = "3",

journal = "Digestive Medicine Research",

issn = "2617-1627",

publisher = "AME Publishing Company",

number = "0",

}

TY - JOUR

T1 - Neoadjuvant chemoradiotherapy for pancreatic cancer is beneficial, but schedules should be improved

AU - Tienhoven, Geertjan van

AU - Versteijne, Eva

AU - Besselink, Marc G.

AU - Wilmink, Johanna W.

AU - Bruynzeel, Anna M.

PY - 2020

Y1 - 2020

U2 - 10.21037/dmr-20-99

DO - 10.21037/dmr-20-99

M3 - Comment/Letter to the editor

SN - 2617-1627

VL - 3

JO - Digestive Medicine Research

JF - Digestive Medicine Research

IS - 0

M1 - 33

ER -